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Abstract
The absence of a dedicated transport for disaccharides in the intestine implicates that the metabolic use of dietary lactose relies on its prior
hydrolysis at the intestinal brush border. Consequently, lactose in blood or urine has mostly been associated with speciﬁc cases in which the
gastrointestinal barrier is damaged. On the other hand, lactose appears in the blood of lactating women and has been detected in the blood
and urine of healthy men, indicating that the presence of lactose in the circulation of healthy subjects is not incompatible with normal
physiology. In this cross-over study we have characterised the postprandial kinetics of lactose, and its major constituent, galactose, in the
serum of fourteen healthy men who consumed a unique dose of 800 g milk or yogurt. Genetic testing for lactase persistence and microbiota
proﬁling of the subjects were also performed. Data revealed that lactose does appear in serum after dairy intake, although with delayed
kinetics compared with galactose. Median serum concentrations of approximately 0·02mmol/l lactose and approximately 0·2mmol/l galactose
were observed after the ingestion of milk and yogurt respectively. The serum concentrations of lactose were inversely correlated with the
concentrations of galactose, and the variability observed between the subjects’ responses could not be explained by the presence of
the lactase persistence allele. Finally, lactose levels have been associated with the abundance of the Veillonella genus in faecal microbiota. The
measurement of systemic lactose following dietary intake could provide information about lactose metabolism and nutrient transport
processes under normal or pathological conditions.
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The disaccharide lactose is the most important energy source
during the 1st year of human life, providing almost half of the
total energy required by infants. However, considering the
absence of intestinal transporters for disaccharides, lactose
needs to undergo hydrolysis into glucose and galactose by
intestinal lactase to be used as a source of energy(1). The ability
to digest lactose into adulthood in many human populations
resulted from genetic mutations enabling the post-weaning
production of lactase by the intestine(2). This adaptation was
probably driven by a positive evolutionary pressure that
provided nutritional beneﬁts, milk being an important source of
energy and water in times of drought as well as a source of
calcium preventing rickets and osteomalacia in regions with
low sunlight(2,3). A complementary mechanism mediating
lactose hydrolysis through adaptation of the colonic microbiota
also contributes to the ability of adults to metabolise lactose(3).
This use of lactose by the intestinal microbiota is similar to the
process that occurs during milk fermentation in which the
resulting production of lactic acid underlies the physical
and chemical transformation of the food. In the context of
these biological processes, and in the absence of a dedicated
intestinal transporter of lactose, the presence of unhydrolysed
lactose in the circulation after ingestion of dairy products,
fermented or not, is not expected.
The identiﬁcation of unhydrolysed lactose in blood (lacto-
saemia) or urine has nevertheless been associated with speciﬁc
cases, such as nursing mothers, newborns(4–6), patients with
gastrojejunostomy(7) or subjects with abnormal intestinal
permeability caused by gastrointestinal disorders, for example
coeliac disease(8) and rotaviral gastroenteritis(9). In this context,
Northrop et al.(10) have proposed urinary lactose, after oral
administration of lactose, as a marker to evaluate intestinal
integrity in adults. However, increases in urinary lactose were
also observed, although at lower levels, in healthy adults after
oral intake of lactose solutions and milk(6,11–13), suggesting
that part of the ingested lactose can also pass through an intact
gastrointestinal barrier to reach systemic circulation and,
subsequently, urine. Indeed, this appeared to be conﬁrmed in
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the work of Pellis et al.(14) who reported, in healthy overweight
men, the presence of lactose in plasma after the ingestion of
a challenge meal based on a milkshake. However, it is note-
worthy in light of the relevance of blood lactose to the diagnosis
of the clinical situations mentioned above, that the ability of
lactose to cross the intestinal barrier to reach blood has not been
actively investigated. In particular, information on: (i) the con-
centrations of lactose that reach the circulation, (ii) the impact, on
these concentrations, of the lactose content of the ingested dairy
products and (iii) the inter-individual variability in blood lactose,
have not been reported. Moreover, lactose uptake might also be
inﬂuenced by the presence of bacteria expressing β-galactosi-
dase, the enzyme responsible for the hydrolysis of lactose. In the
present report, we address these questions by measuring (in
blood) the absorption and clearance of intact lactose from a food
matrix. Samples were obtained from a recently published cross-
over study with fourteen healthy men in which the metabolic
impact of the ingestion of milk and yogurt, two dairy products
that differ in lactose concentration, was evaluated by following
changes in markers of inﬂammation, the faecal microbiota(15), as
well as the serum metabolome(16).
Methods
Details on the experimental design have been published
elsewhere(15).
Subjects
Subjects were healthy men (n 14) recruited by advertisement in
the Lausanne region, with a mean age of 25 years (SEM 1·3,
recruitment range of 18–40 years) and a mean BMI of 22 kg/m2
(SEM 0·5, recruitment range of 18·5–25·0 kg/m2). The ethnicity of
thirteen subjects was Caucasian while one subject was Black
African. A detailed, tabulated description of these subjects has
been published elsewhere(15). No subject reported evidence of
intolerance or adverse reactions to dairy products during the
recruitment process. Exclusion criteria also included dietary
restrictions, dietary supplement intake, chronic or acute
illnesses, regular medication or antibiotic treatment in the
6 months preceding the study. Subjects’ recruitment was con-
ﬁrmed by an inclusion visit consisting in dietary and physical
activity assessments, a physical medical examination, anthro-
pometrics and bioimpedance analysis (ImpDF50; ImpediMed)
and standard clinical biochemistry (fasting glycaemia, insuli-
naemia, lipid proﬁle, full blood count and Fe proﬁle) to ensure
that all aspects of the inclusion criteria were met. Before
entering the study, all subjects provided written informed con-
sent. The study received ethical approval from the Commission
Cantonale d’Ethique de la Recherche sur l’etre humain
(CER-VD, approval no.: 392/13, Vaud, Switzerland); the trial was
registered at clinicaltrial.gov (registration no.: NCT02230345).
Test products
The yogurt investigated in this report was produced by
fermentation of milk with classical yogurt starter cultures
and the probiotic strain Lactobacillus rhamnosus GG (LGG).
Starter cultures were a mix of Lactobacillus delbrueckii ssp.
bulgaricus and Streptococcus thermophilus strains (Thermo-
philic Yoﬂex®; CHR Hansen A/S). The probiotic LGG was
obtained from the Culture Collection of the University of
Göteborg, Sweden (CCUG 34291/ATCC 53103). Starter
cultures and LGG were added simultaneously to the milk and
fermentation was performed at 39°C for 4 h. The non-fermented
milk product was a chemically acidiﬁed full fat milk (3·5%)
prepared by the addition of 2% D-(+ )-glucono-δ-lactone
(GDL≥99·0%; Jungbunzlauer AG). The addition of 2% GDL
to milk mimics the slow pH reduction created during
fermentation, the ﬁnal product having a texture and pH similar
to that of a mild semi-liquid yogurt. This ensured that the
subjects were digesting both products at comparable rates
and allowed the comparison of postprandial kinetics without
the inﬂuence of texture on gastric emptying. The milk used in
both products was provided by Emmi (Mittelland Molkerei AG)
that was derived from a single production batch, homogenised,
ultra-high temperature processed, and stored at 3°C. The
products were prepared at the pilot plant of Agroscope
to industrial standards in accordance with Swiss food
legislation. The ‘Manuel suisse des denrées alimentaires’ was
adhered to at all times. Ingredients and supplements to the
products were used in accordance with Swiss food law.
Lactose was quantiﬁed in the products after β-galactosidase
hydrolysis followed by oxidation of the glucose moiety and
redox reaction using 2,2'-azino-bis(3-ethylbenzothiazoline-
6-sulphonic acid) (ABTS). Galactose was quantiﬁed after
β-galactose dehydrogenase oxidation and assessment of pro-
duced NADH. Both measurements were conducted using the
Thermo ScientiﬁcTM Gallery Automated Photometric Analyzer
(Thermo Fisher Scientiﬁc AG), at 420 nm for ABTS and
340 nm for NADH.
Dietary intervention
The dietary intervention described in the present article was
a randomised, double-blind, cross-over study performed at
the Centre of Clinical Research of the Centre Hospitalier
Universitaire Vaudois in Lausanne. The study was designed to
characterise the effects of acute and semi-chronic intake of
fermented dairy foods, including effects on clinical chemistry
parameters, inﬂammatory markers, serum metabolome and the
faecal microbiome(15). The data presented here relates speciﬁ-
cally to the acute intake of the dairy products. In brief, on each
acute test day, each of the fourteen participants ingested a
single 800 g dose of milk or yogurt within 15min, serum was
taken at ten time points (fasting then 15, 30, 60, 90, 120, 180,
240, 300 and 360min postprandially) and stored at −80°C.
During the 3 weeks preceding each test day, participants con-
sumed 400 g of normal milk/d (200 g morning and evening) and
followed a semi-controlled diet that excluded all dairy products
not provided by the study organisers and included speciﬁc
guidance on portions of fermented foods, alcohol intake and
caffeine intake to replicate normal baseline eating patterns. For
the 3 d before each test day, participants followed a controlled
diet, in free-living conditions(15).
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Genetic test for lactase persistence
Although participants conﬁrmed that they regularly consumed
milk with no signs of adverse reaction, lactase persistence was
evaluated after the completion of the study. To this end, a genetic
test to assess one of the major single nucleotide variants that is
associated with lactase persistence (−13910C>T polymorphism,
rs4988235) was carried out for Caucasian subjects following
completion of the clinical protocol. DNA was prepared from buffy
coats using the Maxwell protocol for DNA extraction (Promega).
Samples were prepared according to the protocol deﬁned by the
EliGene® Lactose Intolerance C-13910T LC Kit (Elisabeth® Phar-
macon). RT-PCR was carried out using the Lightcycler 96 (Roche)
with internal standards for positive and negative controls. Results
were expressed using end-point genotyping.
Serum lactose and galactose GC-MS analysis
Serum samples were prepared to perform untargeted GC-MS
metabolomics; however, the present article focuses on the
analysis of lactose and galactose. Samples were prepared
according to the Human Serum Metabolome Consortium
procedure with small modiﬁcations of the protocol (HUSER-
MET)(17). U13C6-labeled D-fructose (0·17 g/l solution in water)
was used as internal standard (Cambridge Isotope Laboratories,
Inc.). A quantity of 50 μl of the internal standard was added to
100 µl of the serum samples. The mixture was precipitated with
300 μl of acetonitrile (Sigma-Aldrich GmbH) and centrifugated
at 13 000 rpm for 15min. The supernatant (370 µl) was
then lyophilised at room temperature, at 10mbar. A two-step
derivatisation was applied to the dry extract. A quantity of 50 μl
of a 20 g/l O-methoxylamine solution in pyridine (Acros
Organics and Merck Chemicals) were added to the extract
before heating at 80°C for 15min. This was followed by the
addition of 50 μl N-methyl-N-(trimethylsilyl) triﬂuoroacetamide
(Sigma-Aldrich) and a second heating at 80°C for 15min.
Finally, 20 μl of a retention index solution was added before
centrifugation (15min, 13000 rpm) and 100 μl of the supernatant
was used for GC-MS measurement. The retention index solution
consisted in a mix of ﬁve n-alkanes at 0·3 g/l in pyridine (C10,
C12, C15, C19 and C22; Merck Chemicals).
GC-MS measurement was performed on an Agilent
7890B/5977A GC-MS system, 70 kV, equipped with a DB-5MS
column 60m× 0·250mm× 0·25 μm (Agilent Technologies). The
temperature programme was 70°C for 2min, 5°C/min to 160°C
(hold time 0min), 10°C/min to 300°C (hold time 16min). Peak
integration was performed using Agilent MassHunter Quanti-
tative Analysis Software (V.B.7.00; Agilent Technologies).
A total of 1812 metabolites were detected in postprandial serum
using this method, lactose and galactose identities were speci-
ﬁcally conﬁrmed by the injection of pure standard solutions.
Concentrations were calculated from calibration curves using
solutions in water ranging from 7·0× 10−3 to 7·0× 10−1mmol/l
for galactose and 3·5× 10−3 to 3·5× 10−1mmol/l for lactose.
Linear evaluation of the incremental AUC (iAUC) over 6 h was
completed to assess the postprandial lactose and galactose
responses of the organism to the ingestion of the milk and
yogurt products.
Microbiota analysis
The faecal microbiota was assessed at baseline immediately
before the acute intake of each dairy product. Faecal samples
were collected by the participants and stored as described
previously(15). In brief, the samples were processed under
sterile conditions within 4 h of sample collection in glycerol–
brain heart infusion solution and stored at −80°C following
homogenisation by agitation. DNA was extracted using the
QIAamp DNA Mini kit according to the manufacturer recom-
mendations (QIAGEN). The faecal microbiota was examined by
Illumina Miseq sequencing of PCR ampliﬁed V3–V4 variable
region of 16S rRNA. The raw reads were processed with the use
of USEARCH(18) pipeline and Silva database (version 123) as
previously described(15). In addition, the presence of genes
encoding homologs of Escherichia coli β-galactosidase (lacZ)
was evaluated for the dominant bacterial genera (≥5% of all
reads) by assessment of the genome of representative species
with the tblastn algorithm(19).
Statistical analyses
Serum samples used in the present report were obtained
from a published intervention study in healthy men who
ingested milk or yogurt(15). The primary outcome measure of
the study was the untargeted postprandial serum metabolome
as described in clinicaltrial.gov (registration no. NCT02230345).
Given the untargeted nature of the metabolomics analysis,
the desired sample size for the study could not be calculated
a priori and is therefore based on similar published cross-over
nutritional studies that used untargeted metabolomics analyses
on postprandial samples. In particular, a sample size in the
range of ﬁfteen subjects has been shown to give sufﬁcient
statistical power to detect signiﬁcantly regulated metabo-
lites(20–24). Using our untargeted GC-MS method, a total of 1812
metabolites were detected in postprandial serum. Lactose and
galactose were identiﬁed among the metabolites presenting
a signiﬁcant change in postprandial serum after the ingestion
of milk or yogurt (after correction for multiple testing). In
light of the unexpected presence of lactose in serum, lactose
and galactose were speciﬁcally investigated with the
conﬁrmation of their identities and quantiﬁcation using
calibration curves.
All statistical analysis were performed using R (3.1.2), with 0·05
as the P value signiﬁcance cut-off. A paired Wilcoxon’s signed-
rank test was used to compare lactose and galactose intensities
after milk or yogurt intake at each time point and between
subjects with or without lactase persistence. A non-parametric
longitudinal data analysis was performed to test the hypothesis
that a time effect exists during the postprandial phase (package
nparLD version 2.1)(25). The MESS package (version 0.3.2) was
used for calculation of iAUC and the ppcor package (version 1.1)
for the Spearman’s partial correlation test between serum galac-
tose and serum lactose levels. Microbiota analysis was completed
on taxa present at a minimum mean abundance of 0·01% per
volunteer in at least three volunteers as described previously(15).
The relationship between baseline microbiota composition (spe-
cies and genera level analysis) and the postprandial response to
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acute dairy intake for galactose and lactose was explored by
Pearson’s correlation test. Multiple testing was corrected using
the false discovery rate (FDR)(26) and signiﬁcant associations were
considered at FDR <0·10.
Results
Saccharide composition differences between products and
in serum after products intake
The use of lactose by lactic acid bacteria during fermentation of
the milk led to large changes in lactose and galactose composi-
tion of yogurt with a 2-fold decrease in lactose content (48·5 g/l
in milk, 25·2 g/l in yogurt) and a 36-fold increase in galactose
content (0·05 g/l in milk, 1·79 g/l in yogurt). In serum, a dynamic
response of lactose was detected after both intake of milk and
yogurt, with levels remaining higher at 6 h compared with
baseline (Fig. 1(a)). In accordance with the lactose content in the
test products, postprandial lactosaemia was signiﬁcantly higher
after milk intake compared with yogurt intake, from 30 to
360min. Galactose presented markedly different postprandial
kinetics (Fig. 1(b)). While there was little, although signiﬁcant
increase of galactose after milk intake (signiﬁcant time effect,
P= 8·5× 10−4, online Supplementary Fig. S1), clear absorption
and clearance of galactose were observed after yogurt intake
with maximum levels reached after 60min and a return to
baseline by 240min (signiﬁcant time effect, P= 1·2× 10−33).
Median serum concentrations of approximately 0·02mmol/l
lactose and approximately 0·2mmol/l galactose were observed
after the ingestion of milk and yogurt, respectively. Fig. 2 reveals
a signiﬁcant negative correlation between postprandial lactose
and galactose (partial correlation test: Spearman ρ= −0·44,
P= 2× 10−2), suggesting that if less lactose has been cleaved in
the participant’s intestine, more of it is found intact in blood.
Determinants of the postprandial responses to dairy intake
Fig. 2 also indicates inter-individual variability in the postprandial
responses to galactose and lactose. Indeed, the iAUC after yogurt
intake varied across the subjects by a factor of 3·8 for galactose
(x-axis of Fig. 2) and 5·2 for lactose (y-axis of Fig. 2). This varia-
bility is also illustrated for each subject in the online Supple-
mentary Fig. S2 and S3. Interestingly, genetic testing revealed that
eight participants out of fourteen did not have the single
nucleotide variant (T allele, rs4988235) associated with lactase
persistence. However, as illustrated in Fig. 2, there was no clear
differentiation between these two populations. The Wilcoxon’s
signed-rank test comparing serum iAUC after milk intake between
subjects with or without lactose persistence was not signiﬁcant
(P=1 for serum lactose and P= 8·9×10−2 for serum galactose).
The analysis of baseline microbiota before each acute intake
revealed a marked inter-individual variability for the most
dominant genera (Fig. 3(a)) and their ability to express
β-galactosidase (Fig. 3(b)). Nevertheless, the presence of the
genes encoding for the homologs of E. coli β-galactosidase
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Fig. 1. Serum lactose (a) and galactose (b) after milk ( ) and yogurt ( ) intake in fourteen healthy men. Interquartile range plotted. , Median; , outliers.
Significant difference between milk and yogurt intake, * P< 0·05, ** P< 0·005, paired Wilcoxon’s signed-rank test for each time point.
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Fig. 2. Correlation between the postprandial response for serum lactose and
galactose after 800 g dairy intake in fourteen healthy men. Data plotted per
subject for milk (blue) and yogurt (red) intake. Participants with lactase
persistence ( and ) and non-persistence ( and ) according to genetic
testing. Genetic testing not applicable for one participant of Black African origin
( and ). Postprandial incremental AUC (iAUC) in arbitrary units (a.u.). Partial
correlation test among all serum samples after milk or yogurt intake using
Spearman’s method, ρ= − 0·44, P= 2·1 ×10−2.
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(identity> 31%, similarity> 47%, coverage> 97%) could be
demonstrated in the vast majority of the dominant bacteria
(in ten out of twelve examined genomes).
Baseline faecal microbiota analysis revealed that the
postprandial levels of lactose after milk intake were positively
correlated with the abundance of Veillonella genus (Spearman’s
ρ= 0·90, P= 8·8× 10−4, FDR corrected P= 6·4× 10−2)
(Fig. 4) with corresponding positive correlations also being
observed for two species of the same genus, Veillonella
dispar (Spearman’s ρ= 0·89, P= 1·2× 10−3, FDR corrected
P= 7·3× 10−2) and Veillonella atypica (Spearman’s ρ= 0·87,
P= 2·5× 10−3, FDR corrected P= 7·3× 10−2).
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Fig. 3. (a) Baseline microbiota of subjects immediately before yogurt (Y) and milk (M) intake. The graph shows the relative abundance of the major genera
(present> 5% in at least one subject) together with families without genus classification (S24-7 group and vadinBB60 group) and Veillonella genus. The phylum
abbreviations (FIRM, Firmicutes; BACT, Bacteroidetes; PROT, Proteobacteria, VERR, Verrucomicrobia) are followed by class and genus name. (b) Relative
abundance of major genera are coloured on the basis of presence or absence of the β-galactosidase gene.
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Discussion
The presence of lactose in postprandial serum, shown by the
present study, concurs with the existing human clinical data that
report lactose detection in urine after oral intake of lactose. In
healthy men, increases in urinary lactose were reported in 5 h
urine samples after 25 g oral intake of lactose(6,11), and in 3 h
urine samples after 50 g intake(6). Stuhlfauth et al.(12) estimated
that after intake of either 50 g of lactose or 1 l of milk, 1‰ of
the lactose ingested was excreted intact in urine within 24 h.
Menzies(13) obtained similar results, with lactose excretion in
urine ranging from 0·9‰ in lactose tolerant individuals to 2‰
in hypolactasic subjects. The high amounts of lactose used in
previous studies (20–50 g intake) as well as in our study (20 g
and 40 g in yogurt and milk, respectively) could explain its
detection in blood and urine as total lactase activity would be
insufﬁcient to hydrolyse such quantities. A passive diffusion
through the intestinal intercellular tight junctions is likely to
occur at high lactose concentrations, as previously described for
glucose and lactulose(1,27). There is little data reporting on the
blood concentrations of lactose observed in adults. However,
the concentration of 0·058mmol/l observed in pregnant
women(5) is close to the values observed in the present study
(maximum of 0·06mmol/l).
The postprandial behaviour of galactose illustrates the
efﬁciency with which it is absorbed and metabolised or
excreted. In contrast to lactose, intestinal transport of galactose
is mediated by hexose transporters, which explains the rapid
postprandial increase that we observe in serum. Moreover,
absorbed galactose is rapidly metabolised in the liver into
glucose-1-phosphate in the Leloir pathway. Therefore, a post-
prandial increase in systemic galactose can only be observed if
its catabolism in the liver is inhibited (as exempliﬁed in the
Lactose-Ethanol Load Test)(27) or if the ﬂux of galactose exceeds
the capacity for its metabolism. This latter case is observed after
large amounts of milk intake as shown by Kaempf et al.(28) in
lambs, Siegel et al.(29) in newborn infants and, in the present
study, in adults after yogurt intake and, to a lesser extent,
after milk intake (Fig. 1(b)). Compared with galactose, the
slower decrease in serum lactose that was observed after
three hours reﬂects the inability of lactose to be catabolised.
As lactase is exclusively produced by enterocytes, the clearance
of lactose from the blood would rely solely on its urinary
excretion. Indeed, it has been observed that after intravenous
injection of lactose, 86–94% was excreted intact in urine
within 24 h(12,29).
Our study suggested a variability in the postprandial response
to galactose and lactose between the subjects. Genetic testing of
lactase persistence (T allele at rs4988235) was performed in
order to explain this variability but did not clearly differentiate
the responses of lactose and galactose, although there was a
trend towards higher levels of serum galactose after milk intake
in those individuals who did carry the variant allele. Similarly,
the presence of bacterial species in the baseline microbiota was
explored as a contributing factor to the differences in the
postprandial responses of the saccharides. A positive associa-
tion between the relative abundance of several species of the
Veillonella genus and the postprandial response for lactose
after the intake of milk were observed. The Veillonella genus is
known to be part of the small intestine microbiota(30), it lacks
the capacity to metabolise lactose but its ability to use lactate as
a substrate has been well described(31,32). Its abundance in the
microbiota could then be related to the lactose fermentation
activity occurring in the small intestine after dairy intake and the
release of lactate. Bacteria of this genus have been found at
relatively higher abundance in certain cases of inﬂammatory
disease like Crohn’s disease(33), gum disease(34) and obesity-
related inﬂammation(35), although the increases in the same
species accompanied beneﬁcial modulation in the microbiota
after Roux-en-Y gastric surgery(36). One could hypothesise that
this bacteria could affect the integrity of the intestinal gut barrier
and thus lead to higher passive transfer of lactose but further
study would be required to conﬁrm this.
Strengths, weaknesses and implications of the study
In the context of the widespread consumption of dairy products
together with the frequent occurrence of lactose maldigestion
even in the absence of the clinical presentation of lactose
intolerance, there is a public health interest to understand the
metabolic fate of lactose and galactose derived from dairy
products in both metabolic phenotypes. Indeed, this could
have important implications for understanding the potential
consequences of lactose maldigestion and may even support
clinical diagnosis. In our study, the use of dairy products reﬂects
the most common dietary exposure to lactose. Fermented dairy
products are frequently used as a way to reduce lactose intake
while consuming dairy foods and thus provide an interesting
low lactose test product. Dairy products such as milk or yogurt
have speciﬁc digestion kinetics due to the formation of different
phases in the stomach (liquid, lipids and precipitated proteins)
that inﬂuence gastric emptying(37). This characteristic is likely to
inﬂuence the lactose ﬂux across the intestinal barrier and,
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Fig. 4. Correlation between postprandial serum lactose after milk intake and
Veillonella genus abundance in baseline microbiota. Test for correlation using
Pearson’s method, ρ= 0·90, P= 8·8× 10−4, false discovery rate corrected
P= 6·4 ×10−2. iAUC, incremental AUC; a.u., arbitrary units.
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subsequently, its appearance in systemic circulation. The use of
a pure lactose solution in place of the dairy products would
also be a useful model to characterise the mechanisms behind
lactose intestinal absorption by excluding features of the dairy
matrix that inﬂuence these dynamics and could be the subject
of further research.
The application of an untargeted metabolomics strategy
in this study to evaluate the impact of dairy ingestion on the
metabolome of human subjects has revealed unexpected
presence of intact lactose in the blood and opens new avenues
of lactose processing by the organism. Indeed, text book
biochemistry dictates that lactose should not enter the
circulation, transporters for disaccharides being absent, thus
discouraging studies speciﬁcally designed to target the
measurement of lactose in blood or urine. Another strength of
the study is the combined use of genetic information for the
subjects as well as for the gut microbial composition enabling a
discussion on the mechanistic associations between lactose and
galactose in serum and the gut environment. The trends
observed in our study suggest that genetic factors and micro-
biota phenotypes contribute to the variation of the postprandial
responses for lactose and galactose following dairy intake.
These associations are not strong and should be considered
in the context of the limitations of our study. First, the ethnicity
of the subjects participating in the study was not balanced,
thirteen subjects being Caucasian and one Black African. The
genetics of lactase persistence in Africans is more complex and
characterised by several variants(38) whose identiﬁcation was
beyond the scope of this report. Although this imbalance has to
be taken into account when evaluating the inﬂuence of lactase
deﬁciency, the Black African subject was not an outlier
regarding his postprandial kinetics. To some extent, our study
was limited by the relatively small sample size. Untargeted
metabolomics is a recent development in nutritional science
and the method for estimating sample size has not yet been
ﬁrmly established, especially as each measured metabolite
would deserve an individual power analysis. Our sample size
of fourteen participants was nevertheless sufﬁcient to detect
differentially regulated metabolites in serum, including lactose
and galactose. A larger study would be necessary to further
investigate the factors that contribute to the inter-individual
variability and in particular to conﬁrm the trends observed here
for lactase deﬁciency and microbiota composition. Finally,
absolute quantiﬁcation with our GC-MS method could be
improved, notably by conducting targeted analytical measure-
ments of these metabolites or by the use of matrix-match
calibration curves with the lactose and galactose standards.
Further research is warranted to identify the key determinants
of lactose metabolism, which could include microbiota
composition and function, intestinal endothelial integrity and
lactase production.
Conclusions
In summary, we have shown that, despite the absence of an
active transport mechanism for lactose, a fraction of intact
lactose can still reach systemic circulation. Furthermore, the
postprandial behaviour of lactose and galactose suggests
a notable inter-individual variability. This variability could be
contributed to by the lactase production by enterocytes, the
small bowel and enteric microbiota as well as the intestinal wall
integrity(29,39). Measuring systemic lactose could thus contribute
to a better understanding of such processes under normal
or pathological conditions.
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